48 related articles for article (PubMed ID: 38319579)
1. Tumor cell metabolic reprogramming and hypoxic immunosuppression: driving carcinogenesis to metastatic colonization.
Katopodi T; Petanidis S; Anestakis D; Charalampidis C; Chatziprodromidou I; Floros G; Eskitzis P; Zarogoulidis P; Koulouris C; Sevva C; Papadopoulos K; Dagher M; Karakousis VA; Varsamis N; Theodorou V; Mystakidou CM; Vlassopoulos K; Kosmidis S; Katsios NI; Farmakis K; Kosmidis C
Front Immunol; 2023; 14():1325360. PubMed ID: 38292487
[TBL] [Abstract][Full Text] [Related]
2. Glycolysis: an emerging regulator of osteoarthritis.
Jiang D; Guo J; Liu Y; Li W; Lu D
Front Immunol; 2023; 14():1327852. PubMed ID: 38264652
[TBL] [Abstract][Full Text] [Related]
3. Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology.
Kierans SJ; Taylor CT
J Physiol; 2021 Jan; 599(1):23-37. PubMed ID: 33006160
[TBL] [Abstract][Full Text] [Related]
4. Lipid metabolic reprogramming by hypoxia-inducible factor-1 in the hypoxic tumour microenvironment.
Seo J; Yun JE; Kim SJ; Chun YS
Pflugers Arch; 2022 Jun; 474(6):591-601. PubMed ID: 35348849
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic Investigations into Hypoxia-Mediated Metabolic Reprogramming of Pancreatic Cancer Cells.
Chumak V; Rajacharya GH; Singh PK
Methods Mol Biol; 2024; 2755():191-200. PubMed ID: 38319579
[TBL] [Abstract][Full Text] [Related]
6. Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells.
Lee S; Hallis SP; Jung KA; Ryu D; Kwak MK
Redox Biol; 2019 Jun; 24():101210. PubMed ID: 31078780
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-Induced Metabolomic Alterations in Pancreatic Cancer Cells.
Gunda V; Kumar S; Dasgupta A; Singh PK
Methods Mol Biol; 2018; 1742():95-105. PubMed ID: 29330793
[TBL] [Abstract][Full Text] [Related]
8. HIF-1α/YAP Signaling Rewrites Glucose/Iodine Metabolism Program to Promote Papillary Thyroid Cancer Progression.
Song H; Qiu Z; Wang Y; Xi C; Zhang G; Sun Z; Luo Q; Shen C
Int J Biol Sci; 2023; 19(1):225-241. PubMed ID: 36594102
[No Abstract] [Full Text] [Related]
9. ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer.
Dong S; Liang S; Cheng Z; Zhang X; Luo L; Li L; Zhang W; Li S; Xu Q; Zhong M; Zhu J; Zhang G; Hu S
J Exp Clin Cancer Res; 2022 Jan; 41(1):15. PubMed ID: 34998404
[TBL] [Abstract][Full Text] [Related]
10. Excess glucose induces hypoxia-inducible factor-1α in pancreatic cancer cells and stimulates glucose metabolism and cell migration.
Liu Z; Jia X; Duan Y; Xiao H; Sundqvist KG; Permert J; Wang F
Cancer Biol Ther; 2013 May; 14(5):428-35. PubMed ID: 23377827
[TBL] [Abstract][Full Text] [Related]
11. Nucleotide metabolism: a pan-cancer metabolic dependency.
Mullen NJ; Singh PK
Nat Rev Cancer; 2023 May; 23(5):275-294. PubMed ID: 36973407
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia and the Tumor Microenvironment.
Li Y; Zhao L; Li XF
Technol Cancer Res Treat; 2021; 20():15330338211036304. PubMed ID: 34350796
[TBL] [Abstract][Full Text] [Related]
13. Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target.
Infantino V; Santarsiero A; Convertini P; Todisco S; Iacobazzi V
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071836
[TBL] [Abstract][Full Text] [Related]
14. Metabolic adaptation in hypoxia and cancer.
Paredes F; Williams HC; San Martin A
Cancer Lett; 2021 Apr; 502():133-142. PubMed ID: 33444690
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia: a barricade to conquer the pancreatic cancer.
Tan Z; Xu J; Zhang B; Shi S; Yu X; Liang C
Cell Mol Life Sci; 2020 Aug; 77(16):3077-3083. PubMed ID: 31907561
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
